Mon, April 21, 2025
Sun, April 20, 2025
Sat, April 19, 2025
Fri, April 18, 2025
Thu, April 17, 2025
Wed, April 16, 2025

Experimental GLP-1 pill helped people with diabetes lose weight and lower blood sugar, Eli Lilly says

  Copy link into your clipboard //health-fitness.news-articles.net/content/2025/ .. weight-and-lower-blood-sugar-eli-lilly-says.html
  Print publication without navigation Published in Health and Fitness on by CNN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks and lowered their A1C levels.
An experimental oral medication from Eli Lilly, a GLP-1 receptor agonist named orforglipron, has shown promising results in a mid-stage clinical trial for people with type 2 diabetes. The trial, involving 302 participants, demonstrated that the pill effectively lowered blood sugar levels and facilitated weight loss, with participants losing between 3.3 to 8.6 pounds on average, depending on the dosage, compared to a weight gain of 1.1 pounds in the placebo group. The drug was well-tolerated, with the most common side effects being mild to moderate gastrointestinal issues. These findings suggest that orforglipron could be a convenient alternative to injectable GLP-1 therapies, potentially offering a new treatment option for managing type 2 diabetes and aiding weight loss.

Read the Full CNN Article at:
[ https://www.msn.com/en-us/health/other/experimental-glp-1-pill-helped-people-with-diabetes-lose-weight-and-lower-blood-sugar-eli-lilly-says/ar-AA1D67op ]